Global Parenteral Nutrition Market, By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), Consumer Type (Children and New-born, Adults), End-User (Clinic, Hospital, and Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
The body receives nutrients from parenteral nourishment, including sugar, carbs, proteins, fats, electrolytes, and trace elements. These nutrients are essential for preserving high levels of strength, hydration, and energy.
Data Bridge Market Research analyses that the parenteral nutrition market which was USD 6.3 billion in 2021, would rocket up to USD 9.38 billion by 2029, and is expected to undergo a CAGR of 5.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals), Consumer Type (Children and New-born, Adults), End-User (Clinic, Hospital, and Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Baxter (U.S.), Otsuka Pharmaceutical Factory, Inc. (Tokyo), Forbes Media LLC (U.S.), Kelun.com (China), Vifor Pharma Management Ltd. (Switzerland), AbbVie Inc. (U.S.), B.Braun Melsungen AG (Germany), Fresenius SE & Co. KGaA (Germany), Grifols S.A. (Spain), Pfizer, Inc. (U.S.), ICU Medical, Inc. (U.S.), Anhui Medipharm Co., Ltd. (China), aculife (India), Servona GmbH (Germany)
In both developing and established economies, malnourishment is a major contributor to inflammatory bowel disease (IBD), which affects a significant portion of the population. On a larger scale, total parenteral nutrition (TPN) serves as a major treatment for IBD by addressing the nutritional shortage brought by the conclusion of intestinal failure.
Parenteral Nutrition Market Dynamics
- Rising metabolic disorders
One of the key factors driving the expansion of the parenteral nutrition market in the present is the rise in metabolic disorders along with chronic diseases like diabetes. The parenteral nutrition industry will expand as a result of the rising rate of malnutrition in the world. Additionally, one of the main factors driving the expansion of the parenteral nutrition market is the ageing population, which is increasing.
- Increasing chronic diseases
Rapid modernization, poor dietary intake of a balanced diet, and the rising frequency of chronic diseases all contribute to the need for the parenteral nutrition industry.
- Increasing prevalence of malnutrition
The need for parenteral nutrition has increased as a result of the rising incidence of malnutrition around the world. This demand is anticipated to favourably influence the industry's development. Additionally, there was a strong demand for intravenous feeding as a result of the supportive government initiatives to lessen the impact of malnutrition.
The rise in childhood malnutrition, particularly in developing and emerging economies worldwide, is anticipated to fuel the growth of the parenteral nutrition market. Additionally, the parenteral nutrition industry would have promising growth prospects due to the need for parenteral nutrition to properly balance amino acids, lipids, vitamins, minerals, and other nutrients.
Despite this, the acceptability of parenteral feeding products is subject to stringent government regulations, particularly in emerging economies, which will restrain the market's expansion. One of the main obstacles to the growth of the parenteral nutrition industry in the anticipated term is the lack of information among people in developed nations.
This parenteral nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parenteral nutrition market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Parenteral Nutrition Market
The parenteral nutrition market value has been impacted by the extraordinary global health issue caused by the COVID-19 virus outbreak. Parenteral nutrition played a crucial part in the treatment of malnutrition caused by the COVID-19 infection in patients all over the world. A severe lack of appetite brought on by the COVID-19 infection was accompanied by other symptoms that worsened immune defences and caused muscle mass loss. In response to this illness, hospitals and clinics have increased the number of healthcare facilities available for patients who need diet tailored to their sickness. Such advancements are likely to increase patient demand for and adoption of intravenous nutrition administration.
- In July 2021, Micrel Medical, a manufacturer of medical devices with a focus on infusion therapy, and Baxter Healthcare (Baxter) inked a contract. In accordance with this agreement, the businesses would market the infusion pump Micrel Mini Rythmic PN+ for parenteral nutrition (PN).
- Sep 2020: The U.S. Food and Drug Administration (FDA) gave its approval to Baxter International's new Clinimix Injections and Clinimix E Injections formulations. It is easier to reach patient protein targets with the new Clinimix formulations because they contain up to 80 g/L of amino acids, the highest amount of protein in any multi-chamber bag currently available in the United States also contain less fluid and dextrose than previous formulations.
Global Parenteral Nutrition Market Scope
The parenteral nutrition market is segmented on the basis of nutrition type, consumer type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
- Children and New-born
Parenteral Nutrition Market Regional Analysis/Insights
The parenteral nutrition market is analysed and market size insights and trends are provided by country, nutrition type, consumer type, and end-user as referenced above.
The countries covered in the parenteral nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the parenteral nutrition market due to the importance of huge research costs by government agencies and private entities in the healthcare sector.
Asia-Pacific region is anticipated to increase over the course of the forecast period as a result of the economic development of emerging nations and appropriate government initiatives to improve healthcare infrastructure and reimbursement practises.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Parenteral Nutrition Market Share Analysis
The parenteral nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to parenteral nutrition market.
Some of the major players operating in the parenteral nutrition market are:
- Baxter (U.S.)
- Otsuka Pharmaceutical Factory, Inc. (Tokyo)
- Forbes Media LLC (U.S.)
- Kelun.com (China)
- Vifor Pharma Management Ltd. (Switzerland)
- AbbVie Inc. (U.S.)
- B.Braun Melsungen AG (Germany)
- Fresenius SE & Co. KGaA (Germany)
- Grifols S.A. (Spain)
- Pfizer, Inc. (U.S.)
- ICU Medical, Inc. (U.S.)
- Anhui Medipharm Co., Ltd. (China)
- aculife (India)
- Servona GmbH (Germany)
Research Methodology: Global Parenteral Nutrition Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.